As of 2025-07-16, the Fair Value of Sellas Life Sciences Group Inc (SLS) is -1.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.98 USD, the upside of Sellas Life Sciences Group Inc is -168.66%.
With the market price of 1.98 USD and our fair value calculation, Sellas Life Sciences Group Inc (SLS) is not a good investment. Investing in SLS stocks now will result in a potential loss of 168.66%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -16.76 | -20.70 | -41.30 | -37.34 | -31.00 | -29.42 |
| YoY growth | 13.12% | -23.51% | -99.52% | 9.59% | 16.98% | -16.67% |
| Market Cap (mil) | 197.56 |
| P/E | |
| Forward P/E |
| EPS | -0.27 |
| Avg earnings growth rate | -16.67% |
| TTM earnings | -27.13 |